Principles of Prophylactic and Therapeutic Management of Skin Toxicity During Treatment With Checkpoint Inhibitors

Postepy Dermatologii I Alergologii - Poland
doi 10.5114/ada.2018.80272
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Treatment of Helicobacter Pylori: Future Therapeutic and Prophylactic Perspectives

Gut
Gastroenterology
1998English

5) Management of Neurological Adverse Events Associated With Immune Checkpoint Inhibitors

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Workup and Management of Immune‐Mediated Colitis in Patients Treated With Immune Checkpoint Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Role of Immune Checkpoint Inhibitors in Gastrointestinal Cancer Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Combined Total Skin Radiotherapy and Immune Checkpoint Inhibitors: A Promising Potential Treatment for Mycosis Fungoides and Sezary Syndrome

JDDG - Journal of the German Society of Dermatology
Dermatology
2020English

Current State and Perspectives of Checkpoint Inhibitors in Ovarian Cancer Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2020English

Safety of Checkpoint Inhibitors for Cancer Treatment: Strategies for Patient Monitoring and Management of Immune-Mediated Adverse Events

ImmunoTargets and Therapy
AllergyImmunology
2017English

Tumor Kinetics Prior to Treatment Correlate With Response to Checkpoint Inhibitors

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy